(PharmaNewsWire.Com, June 28, 2017 ) The requirement of intravenous immunoglobulins for the treatment of autoimmune diseases develops its importance in the medical sector. To learn more about this blood product, Market Research Hub (MRH) has added a new report to its database which discusses about the intravenous immunoglobulins product types and market expanse. The research study is titled as “Global Intravenous Immunoglobulins Market Research Report 2017”, which also highlights that the market for intravenous immunoglobulins would expand at a positive CAGR growth during the period 2016-2022.
Intravenous immunoglobulin (IVIG) is known to be a blood product created from the serum of between 1000 and 15 000 donors per batch. This product is used for the treatment of various autoimmune, idiopathic and infectious diseases. It is important to know that, IVIG is a permitted treatment for graft versus host disease and ITP. Moreover, it is also accepted for use in patients with Guillain-Barré syndrome, Kawasaki disease and polymyositis/dermatomyositis. Currently, the market reach for intravenous immunoglobulin is spread across the world, with regions such as North America, China, Europe, Southeast Asia, Japan and India enjoying the maximum share. Moreover, the top players functioning in this sector include names like CSL Behring, Octapharma, Grifols, Shire, Bayer, ADMA Biologics and Bharat Serum and Vaccines.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Intravenous Immunoglobulins in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India
Global Intravenous Immunoglobulins market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including CSL Behring Grifols Octapharma Shire ADMA Biologics Bayer Bharat Serum and Vaccines Biotest China Biologic Products Hualan Biological Engineering Kedrion Biopharma Sanquin
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Neurology Hematology Immunology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Intravenous Immunoglobulins for each application, including Hospitals Drugstore Others
Global Intravenous Immunoglobulins Market Research Report 2017 1 Intravenous Immunoglobulins Market Overview 1.1 Product Overview and Scope of Intravenous Immunoglobulins 1.2 Intravenous Immunoglobulins Segment by Type (Product Category) 1.2.1 Global Intravenous Immunoglobulins Production and CAGR (%) Comparison by Type (Product Category) (2012-2022) 1.2.2 Global Intravenous Immunoglobulins Production Market Share by Type (Product Category) in 2016 1.2.3 Neurology 1.2.4 Hematology 1.2.5 Immunology 1.3 Global Intravenous Immunoglobulins Segment by Application 1.3.1 Intravenous Immunoglobulins Consumption (Sales) Comparison by Application (2012-2022) 1.3.2 Hospitals 1.3.3 Drugstore 1.3.4 Others 1.4 Global Intravenous Immunoglobulins Market by Region (2012-2022) 1.4.1 Global Intravenous Immunoglobulins Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 1.4.2 North America Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 China Status and Prospect (2012-2022) 1.4.5 Japan Status and Prospect (2012-2022) 1.4.6 Southeast Asia Status and Prospect (2012-2022) 1.4.7 India Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Intravenous Immunoglobulins (2012-2022) 1.5.1 Global Intravenous Immunoglobulins Revenue Status and Outlook (2012-2022) 1.5.2 Global Intravenous Immunoglobulins Capacity, Production Status and Outlook (2012-2022)
Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
